Stock Taper
eXoZymes, Inc., founded in 2014 in Monrovia, California, develops the SimplePath platform, utilizing enzyme modules for biocatalytic production of chemicals, pharmaceuticals, fuels, materials, and food additives.

A cell-free biomanufacturing platform using AI-engineered exozymes to sustainably produce high-value chemicals for pharma, nutraceuticals, and biofuels, offering a scalable alternative to traditional petrochemical and cell-based methods.
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
GLSI | $15.67 | COMPARE |
SRZN | $22.42 | COMPARE |
CGTX | $1.02 | COMPARE |
ONCY | $0.86 | COMPARE |
TLSA | $1.01 | COMPARE |
TIL | $7.58 | COMPARE |
ESLA | $0.71 | COMPARE |
TVGN | $6.89 | COMPARE |